Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen

Allergic Rhinitis Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01936818
• Other study ID #: 13-100-0008
• Status: Completed
• Phase: N/A
• First received: September 3, 2013
• Last updated: October 21, 2015
• Start date: August 2013
• Est. completion date: January 2015

Study information

• Verified date: October 2015
• Source: ORA, Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

A Multi-Center Study Evaluating the Nasal Allergic Symptomatology Induced by a Nasal Allergen Challenge (NAC) in a Dust Mite Population

Recruitment information / eligibility

• Status: Completed
• Enrollment: 21
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• be at least 18 years of age

• positive ST to Dust Mite

• history of allergic rhinitis

Exclusion Criteria:

• no active infections

• no disallowed medications

• no nasal anatomical deformities or nasal surgical interventions in the past

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Allergic Rhinitis

Locations

Country	Name	City	State
United States	Ora Clinical Research Center	Andover	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
ORA, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	TNSS= total nasal symptoms score		15 minutes	No
Secondary	Individual nasal symptoms		15 minutes	No